• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Coagulation & Plasma Transfusion

Prothrombin Complex Concentrate Increases Risk of Thromboembolic Events in Trauma Patients

Four-factor prothrombin complex concentrate (4F-PCC) is a lyophilized concentrate of coagulation factors that is commonly used for urgent reversal of…

March 29, 2023

Thromboelastometry and Clinical Guidance for Fibrinogen Infusions during Liver Transplantation

Thromboelastometry provides individualized measures of clot kinetics and structure, and has played an increasingly important role in the management of…

February 8, 2023

Plasmapheresis Associated with Reduced Mortality Among Patients with Severe COVID-19

Over 6 million people have died due to COVID-19 worldwide since the start of the pandemic.  Several comorbidities are associated…

January 18, 2023

COVID-19 Convalescent Plasma Improves Outcomes for Cancer Patients

Standard COVID-19 therapies and vaccines have limited effectiveness in patients with impaired humoral immune responses, and these patients have a…

January 10, 2023

Cryopreserved Platelets for Functional Assays

Both heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare but serious drug reactions. HIT and VITT are…

January 3, 2023

Prothrombin Complex Concentrate Reduces RBC Transfusions during Cardiac Surgery

Over one million people undergo complex cardiac surgeries worldwide each year.  Cardiac surgeries carry a considerable risk of postoperative bleeding…

December 21, 2022

High-Titer Convalescent Plasma Increases Long-Term Survival for Patients with Severe COVID-19

Randomized controlled clinical trials have evaluated the safety and efficacy of COVID-19 convalescent plasma (CCP) and found high-titer CCP reduced…

November 16, 2022

Prothrombin Complex Concentrate for Complex Cardiac Surgery Patients

Many cardiopulmonary bypass surgery patients with coagulopathy and bleeding require post-operative plasma transfusions.  Instead of plasma, the off-label use of…

July 14, 2022

Tranexamic Acid in Noncardiac Surgeries

Large randomized clinical trials have shown that tranexamic acid safely reduces bleeding in patients undergoing cardiac surgery or cesarean sections,…

May 3, 2022

AABB Issues COVID-19 Convalescent Plasma Clinical Practice Guidelines

The use of COVID-19 convalescent plasma (CCP) has been highly controversial since the beginning of the pandemic.  With the Food…

April 12, 2022

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 9
  • Go to Next Page »

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley